Objective We aimed to study visfatin level in obesity and its relation with metabolic syndrome (MS).Patients and methods This case-control study included 42 obese children and adolescents and 39 age-matched and sex-matched nonobese children who served as controls. Full medical examination and anthropometric measurements were carried out. Fasting serum total cholesterol, triglycerides, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, blood sugar, insulin, and visfatin were measured. Homeostasis model assessment for insulin resistance (HOMA-IR) was calculated.Results Fasting serum visfatin level was significantly higher in obese children and adolescents compared with controls (8.7 ± 2.8 vs. 3.3 ± 2.3 ng/ml, P = 0.001). Visfatin showed significant positive correlations with waist circumference (P < 0.001), systolic blood pressure (P = 0.001), diastolic blood pressure (P = 0.01), and fasting blood glucose (P = 0.001). Visfatin was significantly higher in obese patients with MS than in patients without MS (10.03 ± 3.2 vs. 7.8 ± 2.2 ng/ml, P = 0.02).Conclusion Visfatin elevated in obese children. Visfatin might be used as a predictor test for the existence of MS in obese children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.